DREADD Agonist 21 is an effective agonist for muscarinic-based DREADDs in vitro and in vivo is a research paper published in Figshare (2020). On theSindex it has a DataRank of 0. It has been cited 23 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5U24DK116195-05
Illuminating the Druggable GPCR-ome
National Institutes of Health
Grant: 1ZIADK075087-05
Probing neural circuits underlying satiety
Wellcome Trust
Grant: 201529
Collaborative Network To Define The Molecular Determinants Of G Protein Coupled Receptor Clinical Efficacy
Wellcome Trust
Grant: unidentified
unidentified
UK Research and Innovation
Grant: MR/P019366/1
MICA Pharmacological, molecular and cellular mechanisms of muscarinic slowing (modification) of neurodegenerative disease.
National Institutes of Health
Grant: 1F31NS093917-01
Regulation of Adult Hippocampal Neurogenesis by Cholecystokinin-Expressing Interneurons
FWCI
1.12
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals